Tender Details

Country: Belarus
Summary: 25-2/I Drug Ruxolitinib (Registered Drug)
BYT Ref No: 129655512
Deadline: 14 Nov 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: BYN 60519577
Notice Type: Tender
Document Ref. No.: EZ20251106354071
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
25-2/I Drug Ruxolitinib (registered drug)
Documents:

Tender Notice

Zayavka_na_pokupku.docx

proekt_dogovor_rezidenty_2025_dlya_ZOI_ETP_posrednik_VF.doc

proekt_dogovor_rezidenty_2025_dlya_ZOI_ETP_proizvoditel_VF.doc

proekt_kontrakta_dlya_nerezidentov_2025_dlya_ZOI_ETP_ZAREG_dlya_VF.doc

zoi_purchase_354071.xls

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

25-2/I Drug Ruxolitinib (Registered Drug) - Belarus Tender

The VITEBSK UNITARY ENTERPRISE "PHARMACY", a Government sector organization in Belarus, has announced a new tender for 25-2/I Drug Ruxolitinib (Registered Drug). This tender is published on BelarusTenders under BYT Ref No: 129655512 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-14.

The estimated tender value is BYN 60519577, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.